Ryan Specialty Quarterly report pursuant to Section 13 or 15(d)

Receivables and Other Current Assets

9 Months Ended

Sep. 30, 2024

Receivables

The Company had receivables of $334.6 million and $294.2 million outstanding as of September 30, 2024 and

December 31, 2023, respectively, which were recognized within Commissions and fees receivable – net on the

Consolidated Balance Sheets. Commission and fees receivable is net of an allowance for credit losses. The Company’s

allowance for credit losses is based on a combination of factors, including evaluation of historical write-offs, current

economic conditions, aging of balances, and other qualitative and quantitative analyses.

The following table provides a summary of changes in the Company’s allowance for expected credit losses:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Beginning of period	$3,153	$2,089	$2,458	$1,980
Write-offs	(1,225)	(441)	(2,510)	(1,342)
Increase in provision	1,691	869	3,671	1,879
End of period	$3,619	$2,517	$3,619	$2,517

Other Current Assets

Major classes of other current assets consist of the following:

Other current receivables contain service receivables from Geneva Re, Ltd. See Note 15, Related Parties, for further

information regarding related parties. See Note 14, Commitments and Contingencies, for further information on the

insurance recoverable.